% Expired Patents = 14.3

CIPO Patents = 3

Trademarks = 13

Forward Citations = 5

Loading Chart...

12 inventors (with patents filed for the assignee):

Robert Birch (3 out of 5 patents)

Michael J Jozwiakowski (3 out of 5 patents)

Andrea Bauer (3 out of 6 patents)

4. Ulrich Bildmann (3 out of 3 patents)

5. Paul Mcglynn (3 out of 9 patents)

6. Helgert Müller (3 out of 8 patents)

7. Renate Engelstätter (3 out of 3 patents)

8. Antje Brueck-Scheffler (1 out of 1 patent)

9. Edith Mathiowitz (57 patents)

10. Solomon S Steiner (59 patents)

11. Bryan E Laulicht (0 patent)

12. Sasha H Bakhru (0 patent)

7 patents: Sort by Forward Citations

1. 12370141 - Pharmaceutical aerosol product for administration by oral or nasal inhalation (2025-07-29),

2. 11992556 - Pharmaceutical aerosol product for administration by oral or nasal inhalation (2024-05-28),

3. 11730744 - Methods of reducing risk of preterm birth (2023-08-22),

4. 11304962 - Methods of reducing risk of preterm birth (2022-04-19),

5. 11154562 - Methods of reducing risk of preterm birth (2021-10-26),

6. 11052042 - Aqueous suspensions of ciclesonide for nebulisation (2021-07-06),

7. 11007150 - Pharmaceutical aerosol product for administration by oral or nasal inhalation (2021-05-18),

Company Overview

Covis Pharma is a global specialty pharmaceutical company that markets therapeutic solutions across a range of therapeutic areas. With a focus on cardiology, central nervous system, hospital acute care, and respiratory markets, Covis Pharma is committed to improving patient lives through innovative and high-quality products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#71 in Zug

#1,340 in Switzerland

Zug, Switzerland

Covis Pharma Gmbh

Forward Citations = 5

12 inventors:

Robert Birch (3 out of 5 patents)

Michael J Jozwiakowski (3 out of 5 patents)

Andrea Bauer (3 out of 6 patents)

4. Ulrich Bildmann (3 out of 3 patents)

5. Paul Mcglynn (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Covis Pharma Gmbh. Retrieved from https://idiyas.com/company/covis-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]